On 15th August, the medical devices company Shenzhen Xpect Vision Technology(Xpect Vision Technology) completed nearly 100 million yuan B round of financing, led by Shenzhen Time Bole Venture Capital Investment. Previously, XpectVision Technology got the 40 million yuan Pre-B round of financing from Guoke Holdings and IDG Capital in April 2018, and the A round of financing in June 2016.
"This round of financing will be used in several aspects: Firstly, to optimize the performance of the quantum counting X-ray detection chip. Secondly, to accelerate the mammography machine's R&D, registration certification and the whole machine trial production. Thirdly, to develop the TOMO version of the mammography machine, synchrotron radiation detector, ultra-low-dose DSA angiography, XRF detector, and other new products," said Cao Peiyan, the founder of Xpect Vision Technology.
Founded in 2015, Xpect Vision Technology is a high-tech company committed to disruptive and innovative technology development. XpectVision has been trailblazing in the field of photon-counting X-ray imaging. The company is poised to be the leader of other futuristic imaging technology, including high-speed high-definition imaging chip. XpectVision is currently headquartered in Shenzhen and has R&D branches in Beijing and Shanghai respectively. It has obtained 16 patents in the United States, China, Japan, Singapore, Taiwan, and other countries or regions, covering a large number of underlying core technologies such as semiconductor devices, integrated circuits, and manufacturing processes.
The development of quantum counting X-ray detector is a huge success for XpectVision, which has taken a big step in the history of medical X-ray imaging.
The quantum counting technology was originally applied mainly in the field of high-energy physics, but the promotion for civil use faced multiple difficulties such as technology and cost.
The company's Quantum clearing mammography machine is equipped with a quantum counting detector designed and developed by itself. With an 18-bit digital image output, good image quality, it meets the needs of large-scale promotion.
Compared with the traditional imaging technology, quantum counting imaging technology has lower system noise and achieves zero dark noise. Thus, it greatly expands the dynamic range of the system, improves image linearity and quality.
Based on the technologies and products mentioned above, the company has officially launched the mammography DR equipment last year. It will release quantum counting mammography machine, synchrotron radiation detectors, and other products in the future.
Shenzhen Time Bole Venture Capital Investment
Shenzhen Time Bole Venture Capital Investment Co Ltd is a private equity firm. This company invests in growth and pre-IPO stage across various industries including healthcare, manufacturing, consumer and media in China.